Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE is a paper indexed in PICO Portal from OpenAlex.
How many citations does Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE have?
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE has 239 citations in the OpenAlex counts PICO Portal stores.
When was Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE published?
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE has 2006 year in the PICO Portal index.
What is the open-access status of Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE?
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE has closed oa status in the PICO Portal index.
What is the DOI of Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE?
The DOI for Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE is on the source record.
What is the PMID of Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE?
The PMID for Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE is on the source record.
What is the OpenAlex record for Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE?
The OpenAlex for Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE is on the source record.